nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Additional Notes on Clinical Repeated-Dose Pharmacokinetic Trials Applying a Peak-and-Trough Sampling Design to Estimate Oral Clearance
|
Takaai, Mari |
|
2008 |
23 |
2 |
p. 128-133 6 p. |
artikel |
2 |
CYP2D6 is Primarily Responsible for the Metabolism of Clomiphene
|
Ghobadi, Cyrus |
|
2008 |
23 |
2 |
p. 101-105 5 p. |
artikel |
3 |
Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
|
Sai, Kimie |
|
2008 |
23 |
2 |
p. 139-147 9 p. |
artikel |
4 |
Interaction between Tacrolimus and Lansoprazole, but not Rabeprazole in Living-Donor Liver Transplant Patients with Defects of CYP2C19 and CYP3A5
|
Hosohata, Keiko |
|
2008 |
23 |
2 |
p. 134-138 5 p. |
artikel |
5 |
Intestinal First-Pass Metabolism of CYP3A4 Substrates
|
Kato, Motohiro |
|
2008 |
23 |
2 |
p. 87-94 8 p. |
artikel |
6 |
No Effect of Imidafenacin, a Novel Antimuscarinic Drug, on Digoxin Pharmacokinetics in Healthy Subjects
|
Nakade, Susumu |
|
2008 |
23 |
2 |
p. 95-100 6 p. |
artikel |
7 |
P-glycoprotein Limits the Brain Penetration of Olopatadine Hydrochloride, H1-Receptor Antagonist
|
Mimura, Nobuhito |
|
2008 |
23 |
2 |
p. 106-114 9 p. |
artikel |
8 |
Pharmacokinetics and Pharmacodynamics: Where are they going?
|
Takano, Mikihisa |
|
2008 |
23 |
2 |
p. 85-86 2 p. |
artikel |
9 |
Rapid Characterization of Drug-drug Interaction in Plasma Protein Binding using a Surface Plasmon Resonance Biosensor
|
Kuroda, Yukihiro |
|
2008 |
23 |
2 |
p. 120-127 8 p. |
artikel |
10 |
The Effect of Bucolome, a CYP2C9 Inhibitor, on the Pharmacokinetics of Losartan
|
Kobayashi, Mariko |
|
2008 |
23 |
2 |
p. 115-119 5 p. |
artikel |